This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA
Book Now
Menu
Book
Key Sessions
Mark Cobbold
Strategies to Overcome Limitations of Cell Therapies in Cancer Treatment
AstraZeneca
Timothy Nelson, MD, PhD
Keynote: Advancing Regenerative Medicine with Autologous Induced Pluripotent Stem Cell (iPSC)-derived Therapies
HeartWorks
keyboard_arrow_right

Wednesday, September 25, 2024 - Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search

Wednesday, September 25, 2024 - Day Two - ET (Eastern Time, GMT-05:00)

search
7:30am - 8:15am
Registration and Morning Coffee
Showing 5 of 5 Streams
8:15am - 8:45am
Scientific Breakfast with Endress + Hauser
8:15am - 8:45am
Scientific Breakfast with Bio-Rad
8:15am - 8:45am
Scientific Breakfast with Repligen
8:15am - 8:45am
Scientific Breakfast with Fujifilm Irvine
8:15am - 8:45am
Scientific Breakfast with Sartorius
8:45am - 9:00am
Transition to Plenary Sessions
Showing 1 of 1 Streams
9:00am - 9:10am
Chairperson's Remarks
9:10am - 9:50am
Strategies to Overcome Limitations of Cell Therapies in Cancer Treatment
  • Mark Cobbold - Senior Vice President Discovery and Head of Oncology Cell Therapy - Oncology R&D, AstraZeneca
9:50am - 10:10am
Keynote Address from Cytiva
10:10am - 10:30am
Keynote Address from Emerson Automation Solutions
10:30am - 11:25am
Networking Refreshment Break in the Exhibit Hall
Showing 3 of 3 Streams
11:25am - 11:35am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
11:35am - 12:20pm
Keynote: Advancing Regenerative Medicine with Autologous Induced Pluripotent Stem Cell (iPSC)-derived Therapies
  • Timothy Nelson, MD, PhD - Founder & CEO, HeartWorks
12:20pm - 12:50pm
Scientific Track Presentation by Intertek
11:25am - 11:30am
Chairperson’s Opening Remarks: Cell Therapy Manufacturing
  • Amish Patel - SVP, Technical Operations, Calidi Biotherapeutics
11:30am - 12:00pm
Building the capabilities for success in Cell Therapy Commercialization
  • Kenneth Green, PhD - Snr Dir MSAT, Vertex
12:00pm - 12:30pm
Transitioning from manual to automated processing in autologous CAR T manufacturing: a case study
  • Sylvain Roy - CTO, ImmPACT Bio
12:30pm - 1:00pm
Scientific Track Presentation by WuXi Advanced Therapies
11:25am - 11:30am
Chairperson’s Opening Remarks: Gene Therapy Manufacturing
11:30am - 12:00pm
Computational Modelling to Improve Output and Efficiency via an Intensified Perfusion Process
  • Tam Nguyen - Scientist, BioNTech US / Massachusetts Institute of Technology
12:00pm - 12:30pm
Novel Cell Engineering Platform for High-Yield AAV Production and Improved Manufacturability
  • Larry Forman - CEO, CHO PLUS
12:30pm - 1:00pm
Scientific Track Presentation by Avantor
1:00pm - 2:10pm
Luncheon in the Exhibit Hall
Showing 3 of 3 Streams
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
2:15pm - 2:45pm
Complex miRNA: The next generation of in vivo epigenetic therapies improving patient outcomes
  • Joseph Chalifoux - Founder & CEO, Athergen
2:45pm - 3:15pm
The Next Frontier in Synthetic Biology: Novel DNA-based Platforms for Non-Viral In-Vivo Gene Therapy and Vaccines
  • Martin Williams - Founder and CEO, SYTE.bio
3:15pm - 3:45pm
Scientific Track Presentation by Cytiva
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Cell Therapy Manufacturing
2:15pm - 2:45pm
Automation-Enabling Design Considerations for Cell Therapy Manufacturing and Testing Systems
  • Dmitry Fradkin - Director of Automation Systems Development, Kite Pharma
2:45pm - 3:15pm
Considerations for Cryopreservation of Allogeneic NK-Cell Drug Product
  • Rae Stephenson - Senior Research Associate - Cell Therapy Drug Product, Sanofi
3:15pm - 3:45pm
Scientific Track Presentation by Innoforce
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Gene Therapy Manufacturing
2:15pm - 2:45pm
Late-stage Development of UX701 AAV Gene Therapy for Wilson Disease
  • Jun Li - Associate Director, Upstream Process Development, Gene Therapy, Ultragenyx Pharmaceutical
2:45pm - 3:15pm
Expanding the upstream toolbox: Enabling high-productivity, robust, and scalable AAV production by suspension transient transfection
  • Paetra Brailsford - Engineer III, Technical Development, Biogen
3:15pm - 3:45pm
Scientific Track Presentation by Thermo Fisher
3:45pm - 4:30pm
Networking Refreshment Break in Exhibit Hall
Showing 3 of 3 Streams
4:30pm - 5:00pm
Building a mass-scale cell therapy for corneal endothelial disease
  • Eris Jordan - Global Vice President, Clinical and Medical Affairs, Aurion Biotech
5:00pm - 5:30pm
Clinical manufacturing of an arenavirus-based immuno-virotherapy: challenges and solutions
  • Dethardt Müller - Chief Technology Officer - CMC, Abalos Therapeutics GmbH
4:30pm - 5:30pm
Bridging the Gap from Bench to Batch
  • How can early-stage/research professionals best prepare for GMP
  • Critical aspects to keep in mind transitioning from early-stage development into more commercial manufacturing.
  • Examples from experiences and lessons learnt
  • Cross-team collaboration and pre-emptively preventing down the road bottlenecks
  • Shashi Murthy, PhD - CTO and Co-Founder, Nanite Inc.
  • Jared Auclair, PhD - Vice Provost Research Economic Development, Director of Bioinnovation, College of Science at Northeastern University
4:30pm - 5:30pm
Bridging the Gap from Bench to Batch
  • How can early-stage/research professionals best prepare for GMP
  • Critical aspects to keep in mind transitioning from early-stage development into more commercial manufacturing.
  • Examples from experiences and lessons learnt
  • Cross-team collaboration and pre-emptively preventing down the road bottlenecks
  • Shashi Murthy, PhD - CTO and Co-Founder, Nanite Inc.
  • Jared Auclair, PhD - Vice Provost Research Economic Development, Director of Bioinnovation, College of Science at Northeastern University
5:30pm - 8:30pm
BWB Festival
8:30pm - 8:35pm
Close of Main Conference Day 2
Tuesday, September 24, 2024 - Day One
NextThursday, September 26, 2024 - Day Three
Filter
Streams
Choose Day